UnitedHealthcare Trades 1.3M MA Members for Margin Gains in the Largest Medicare Advantage Repricing in History

From analyzing the MA enrollment and financial data across the five largest plan sponsors over the past three years, UnitedHealthcare's margin-over-volume pivot stands out as the most deliberate repricing strategy in Medicare Advantage history. The numbers tell a story that goes well beyond the headline membership loss. UnitedHealthcare entered 2026 with approximately 8.4 million MA members and a Medical Care Ratio that had drifted toward 90% through mid-2025, threatening the margin structure that supports the largest Medicare Advantage book in the country. Management chose to reprice aggressively, cut supplemental benefits, exit 190 counties across 16 states, and accept a projected loss of 1.3 to 1.4 million MA members rather than continue subsidizing volume with deteriorating per-member economics.

The Q1 2026 results validated the financial thesis. UnitedHealth Group reported consolidated revenue of $111.7 billion, earnings from operations of $9.0 billion, and an MCR of 83.9%, down 90 basis points year over year from 84.8% in Q1 2025. Adjusted EPS came in at $7.23, and management raised the full-year 2026 adjusted EPS floor to $18.25. The question facing health plan actuaries is not whether the repricing worked in the short term. It clearly did. The question is whether trading 1.3 million members for 50 basis points of margin improvement creates competitive and risk pool dynamics that compound against UnitedHealthcare over the next two to three bid cycles.

The Scale of the Membership Exit

UnitedHealthcare's membership contraction is the largest deliberate reduction in Medicare Advantage program history. The breakdown reported through Q1 2026 includes approximately 965,000 MA seniors and 220,000 Medicaid managed care members, with an additional 180,000 members affected by county-level plan withdrawals. The total projected membership decline across all lines of business reaches 2.3 to 2.8 million for full-year 2026, representing a contraction of roughly 11% in the MA book alone.

The initial guidance issued in early 2026 projected approximately 1 million MA member losses. By the Q1 earnings call in April, management revised that figure upward to 1.3 million, with language characterizing the attrition as a "deliberate trade-off" prioritizing margin recovery and product stability. The revision signals that the repricing was more aggressive than originally modeled, or that member sensitivity to benefit reductions exceeded the retention assumptions embedded in the original bid filings.

To contextualize the scale: KFF reported that total Medicare Advantage enrollment reached approximately 35 million as of February 2026, representing 55% of all eligible Medicare beneficiaries. UnitedHealthcare's 1.3 million member loss represents roughly 3.7% of the total national MA enrollment moving in a single plan year. No single carrier has voluntarily shed this volume of MA membership in the program's history. The closest precedent was the 2025-2026 wave of involuntary plan exits documented by JAMA, which forced 2.9 million beneficiaries to switch plans across all carriers combined.

Metric	Q1 2026	End-2025 Baseline	Change
MA Seniors Lost	965,000	~8.4M base	-11.5%
Medicaid Members Lost	220,000	N/A	N/A
Counties Exited	190	N/A	N/A
Members Affected by Exits	180,000	N/A	N/A
Total Projected Loss (All Lines)	2.3-2.8M	49.8M total	-4.6% to -5.6%

The Financial Recovery: From Near-90% to 83.9% MCR

The margin improvement math is straightforward once you decompose the MCR movement. UnitedHealthcare's Medical Care Ratio reached approximately 90% at the segment level during mid-2025, a level that threatened the operating margin structure needed to support Optum's integrated care model and the parent company's 3.2% consolidated operating margin target. By Q1 2026, the MCR had improved to 83.9%, a 90 basis point year-over-year decline from Q1 2025's 84.8% print.

Several factors drove the improvement beyond simple premium repricing. UnitedHealth Group's Q1 2026 10-Q shows approximately $500 million in favorable prior-year reserve development, suggesting that the claims reserves established during the high-MCR period of 2025 proved conservative as actual paid claims came in below estimates. This reserve release flatters the reported MCR and will not repeat in future quarters at the same magnitude. Pricing actuaries tracking the margin recovery trajectory should strip the reserve development to isolate the underlying current-period MCR improvement.

The full-year 2026 financial guidance frames the broader margin recovery thesis. Management projects adjusted EPS exceeding $18.25, with approximately 13% growth in adjusted operating earnings. The targeted operating margin of 3.2% on projected revenue above $400 billion implies operating earnings in the range of $10.8 billion. For context, UnitedHealth Group's Q1 2026 operating cash flow reached $8.9 billion, representing 1.4 times net income, a ratio that indicates the cash generation engine remains strong even as the MA book contracts.

The repricing levers went beyond premium adjustments. Benefit design changes effective January 1, 2026, tightened supplemental benefit eligibility for Special Needs Plan members, requiring qualifying chronic conditions to access healthy food and utility allowances. HMO and POS plans now require referrals for specialist visits, a utilization management lever that directly reduces the MCR by gating access to higher-cost services. The plan maintained "$0 premium, $0 copay for primary care and Tier 1 prescriptions" messaging to preserve acquisition appeal, but the underlying benefit richness declined measurably. This pattern aligns with the broader KFF finding that MA premiums fell to $14.00 on average while supplemental benefits eroded across OTC, meals, and transportation categories.

Competitive Absorption: Humana Takes the Volume, Pays the Price

The most consequential competitive dynamic in the 2026 MA market is the volume transfer from UnitedHealthcare to Humana. Humana reported Q1 2026 revenue of $39.6 billion, a 24% year-over-year surge, driven by individual MA membership reaching 6.4 million, a 23% increase. The company absorbed approximately 1.2 million new MA members during the period when UnitedHealthcare was shedding them.

The financial cost of that absorption is visible in Humana's Medical Benefit Ratio. Humana's Q1 2026 MBR spiked 240 basis points to 89.4%, reflecting the higher medical costs associated with onboarding a large cohort of members who may have been systematically underserved by UnitedHealthcare's repriced benefit designs. When a carrier cuts supplemental benefits, tightens referral requirements, and exits counties, the members who leave first tend to be those with the highest care needs and the strongest motivation to find richer coverage elsewhere. Humana's 89.4% MBR, sitting 550 basis points above UNH's 83.9%, quantifies the adverse selection cost of absorbing another carrier's repricing runoff.

Humana's management framed the enrollment surge as strategic, targeting "doubling individual Medicare Advantage margins" over the course of 2026 as the new cohort seasons and as Humana's own pricing actions take effect. The company's Star Ratings position complicates this thesis. Only approximately 20% of Humana's members are enrolled in 4-star or above plans, with an average star rating of 3.61, well below the 4.0 threshold that triggers quality bonus payments from CMS. By comparison, UnitedHealthcare has roughly 78% of members in 4-star or above plans, and CVS/Aetna exceeds 81%. The Star Ratings gap means Humana's newly acquired members generate lower per-member revenue from quality bonuses, further pressuring the MBR math.

Metric	UnitedHealthcare	Humana	CVS/Aetna
Q1 2026 MBR/MCR	83.9%	89.4%	N/A
MA Membership Change	-1.3M	+1.2M	Reducing ~90 plans
Members in 4+ Star Plans	~78%	~20%	>81%
Revenue Growth	+2% (consolidated)	+24%	N/A
Strategic Posture	Margin recovery	Volume capture	Selective pruning

The broader competitive field shows a mixed response to the same market pressures. CVS/Aetna is closing approximately 90 MA plans across 34 states, reducing geographic coverage from 2,259 counties to 2,159 counties. Elevance Health reported approximately 150,000 individual and group MA members affected by plan exits. Smaller carriers Molina Healthcare and UCare entirely abandoned Medicare Advantage. At the other end, Blue Cross/Blue Shield of Minnesota, Medica, and Devoted Health all expanded their MA footprints, along with Humana.

The 190-County Exit Map: Geographic Risk Selection at Scale

UnitedHealthcare's withdrawal from 190 counties across 16 states represents a geographic risk selection exercise at a scale the MA program has not previously seen from a single carrier. The exits concentrated in rural areas where provider networks are thinner, utilization patterns are less predictable, and the administrative costs of maintaining network adequacy compliance are higher relative to enrollment volume. Florida, Minnesota, and Vermont were among the states with the most significant withdrawals, with PPO plans specifically dropped in Minnesota and Vermont.

For health plan actuaries building county-level bid models, the exit pattern carries several implications. First, the counties UnitedHealthcare exited are disproportionately markets where CMS benchmark rates may not have kept pace with local medical cost trends. When the largest carrier in a market exits, it signals that the carrier's internal actuarial analysis concluded the benchmark rate is inadequate to support the benefit design members expect. Second, the exit removes the largest risk pool from those counties, potentially destabilizing the remaining carriers' experience data. Third, the exit feeds back into CMS rate calculations through the fee-for-service spending data that anchors benchmark rates. As health systems increasingly drop MA contracts, the remaining fee-for-service spending in those counties may shift upward as higher-acuity patients return to traditional Medicare, paradoxically improving benchmark rates for future years.

The geographic exits interact with the broader provider network adequacy crisis. At least 21 health systems exited Medicare Advantage networks in 2026, including Mayo Clinic, Mount Sinai, and Providence. When a major carrier exits a county and the remaining carriers face network adequacy challenges from simultaneous provider departures, the coverage gap for beneficiaries compounds. CMS network adequacy standards require plans to maintain minimum provider-to-enrollee ratios and maximum travel time standards, but these standards were designed for a market where carriers were expanding, not contracting.

CMS Rate Dynamics and the V28 Feedback Loop

The 2026 CMS rate environment provided a partial tailwind for MA plan economics. The final 2026 rate notice delivered an effective growth rate of 9.04%, translating to a 5.06% total payment increase worth approximately $25 billion to the MA program. This represented a meaningful improvement from the advance notice's 5.93% effective growth rate, giving plans additional margin to absorb the final year of the V28 risk adjustment model phase-in.

The V28 model, which reached full weight in payment year 2026, reduced the number of valid ICD-10 diagnosis codes from 9,797 to 7,770 and projected average risk score compression of 3.12%. For UnitedHealthcare specifically, the V28 compression created a revenue headwind on the remaining membership. Combined with the DOJ's ongoing criminal and civil investigations into UnitedHealth's Medicare billing practices, including allegations of inflated risk scores and diagnoses added without physician confirmation, the risk adjustment environment favored a strategy of shedding marginal members whose risk-adjusted revenue might not survive increased coding scrutiny.

Looking forward, the CMS 2027 final rule established a 2.48% average effective rate change, a significant improvement from the advance notice's near-flat 0.09% proposal. The 2027 rate, while positive, represents a substantial deceleration from the 2026 rate cycle. For UnitedHealthcare's bid actuaries, the 2027 rate environment tests whether the margin gains achieved through the 2026 repricing can be sustained when rate growth falls below medical trend. If medical trend runs in the 7% to 8% range and CMS rates grow at 2.48%, the gap must be filled by continued benefit reductions, further geographic exits, or acceptance of margin compression.

The rate adequacy question becomes more pointed as UnitedHealthcare's exit from 190 counties removes a significant volume of MA utilization data from those markets. CMS rate-setting relies on fee-for-service spending in each county as the benchmark anchor. When MA penetration declines in a county because the largest carrier exits, the mix of beneficiaries remaining in fee-for-service shifts. If healthier beneficiaries disproportionately enrolled in MA plans that still operate in those counties, the remaining fee-for-service population skews sicker, potentially inflating the benchmark for future years. This feedback loop benefits carriers that remain in the market but penalizes carriers that exited by making re-entry more expensive.

Risk Pool Mechanics: Adverse Selection Flowing in Both Directions

UnitedHealthcare's repricing creates adverse selection dynamics that flow in two directions simultaneously. The Wall Street Journal documented a pattern in which the sickest Medicare Advantage patients cancel coverage as their health needs intensify, switching to traditional Medicare at double the rate of healthier enrollees. MA patients in their last year of life were far more likely to leave MA plans for fee-for-service Medicare. This "upward selection" has existed as a structural feature of MA for years, but UnitedHealthcare's repricing accelerates it.

When a carrier cuts supplemental benefits, particularly the dental, vision, OTC allowance, and transportation benefits that high-need seniors rely on, it accelerates the departure of members with the highest utilization. These members are also the most expensive, so their departure improves the carrier's MCR mechanically. But these members also carry the highest risk scores under the CMS-HCC model, meaning their departure reduces the plan's risk-adjusted revenue per member. The net effect on plan economics depends on whether the margin improvement from lower claims costs per member exceeds the revenue reduction from lower average risk scores.

The second adverse selection vector runs in the opposite direction. Healthier, cost-conscious seniors who chose UnitedHealthcare for its supplemental benefit package may switch to competitors offering richer benefits, even if their claims costs are low. When healthy members leave, the remaining risk pool concentrates toward higher-cost members, degrading the MCR from the denominator side. This is the classic adverse selection spiral that health actuaries model in ACA individual market pricing, now playing out within a single carrier's MA book.

The accelerating shift toward Special Needs Plans adds another dimension to the risk pool dynamics. SNP enrollment reached 8.0 to 8.2 million in February 2026, driving 83% of total MA growth. UnitedHealthcare's repricing of its standard MA book, combined with tighter supplemental benefit eligibility for SNP members, may push dual-eligible and chronically ill members toward D-SNP and C-SNP products offered by competitors. Since SNP members carry significantly higher risk scores and generate higher risk-adjusted revenue, losing them to competitors represents a larger per-member revenue hit than losing standard MA seniors.

The Break-Even Calculus: When Volume Erosion Exceeds Margin Gains

The core actuarial question is whether UnitedHealthcare's margin-over-volume strategy has a sustainable equilibrium or whether the competitive erosion becomes self-reinforcing. A simplified framework illustrates the tension.

Assume UnitedHealthcare's pre-repricing MA book generated approximately $15,000 in annual revenue per member (consistent with national MA per-capita spending trends reported by MedPAC) at a 90% MCR, producing $1,500 in gross margin per member. The 2026 repricing reduced enrollment by 1.3 million members while improving the MCR to 83.9%, increasing gross margin to approximately $2,415 per remaining member. On the smaller base of 7.1 million members, total gross margin rises from approximately $12.6 billion (8.4M x $1,500) to approximately $17.1 billion (7.1M x $2,415). Even accounting for simplification, the math explains why management is projecting 13% operating earnings growth despite an 11% membership decline.

The break-even threshold is the enrollment level at which per-member margin gains no longer offset total volume losses. If UnitedHealthcare's enrollment continues to decline at 1.3 million per year while the MCR holds at 83.9%, the crossover point occurs when the remaining member base becomes too small to support the fixed cost infrastructure: provider contracting teams, compliance operations, CMS reporting, Star Ratings management, and the technology stack that supports claims processing. These costs do not scale linearly with membership. A carrier with 7 million members has nearly the same compliance burden as a carrier with 8.4 million, but spreads it across fewer premium dollars.

Provider bargaining leverage adds another nonlinearity. UnitedHealthcare's network contracts are negotiated partly on the basis of volume guarantees. As membership declines, the carrier's ability to steer patient volume to preferred providers diminishes, weakening its negotiating position on unit cost rates. If provider reimbursement rates increase as a result, the MCR deteriorates even if utilization per member holds steady.

The SNP Pivot and the Restructured MA Playbook

Beneath the headline membership losses, UnitedHealthcare is restructuring its MA product mix. The company is increasingly favoring HMO products over PPOs in remaining markets, tightening referral requirements, and pivoting toward managed care models that give Optum's provider network greater control over utilization. The strategy leverages UnitedHealth Group's vertical integration: Optum Health employs or affiliates with approximately 90,000 physicians, giving UnitedHealthcare a captive provider network that can absorb utilization shifts without renegotiating third-party contracts.

The SNP segment is central to this restructuring. While UnitedHealthcare tightened standard MA benefits, it maintained its dominant position in D-SNP and C-SNP products. UnitedHealth Group holds approximately 51% of the SNP market by enrollment, and SNP members generate higher risk-adjusted revenue per capita than standard MA members. The repricing strategy implicitly prioritizes retaining the higher-margin SNP book while accepting attrition in the lower-margin standard MA product lines.

This product mix shift has implications for UnitedHealthcare's CMS Star Ratings trajectory. Star Ratings are calculated at the contract level, and contracts that lose healthier standard MA members while retaining sicker SNP members may see changes in HEDIS scores, CAHPS survey results, and pharmacy quality metrics. If the remaining member base has higher acuity and more complex care needs, the clinical quality measures that now drive approximately 65% of the Star Ratings score become harder to maintain at 4-star thresholds. The Star Ratings exposure represents a lagged risk that will not materialize until the 2027 or 2028 measurement periods.

Why This Matters for Health Plan Actuaries

UnitedHealthcare's margin-over-volume pivot creates ripple effects across every health plan actuarial function.

Pricing and bid actuaries at competing plans need to model the composition of the 1.3 million members now shopping for new MA coverage. If Humana's 89.4% MBR is any indication, the attrition cohort carries higher medical costs than the average MA enrollee. Plans that absorbed large shares of UnitedHealthcare's departed members should stress-test their 2027 bids against the emerging claims experience from this cohort, rather than assuming the new members will blend seamlessly into existing risk pools. The favorable prior-year reserve development in UNH's Q1 results also warrants attention: if UNH over-reserved for the repriced population, competing plans may be under-reserving for the same members.

Network actuaries should track provider contract renegotiations in the 190 counties UnitedHealthcare exited. When the largest payer leaves a market, remaining plans lose the benefit of UNH's negotiated rates as a competitive anchor. Providers may seek rate increases from remaining carriers to compensate for lost patient volume, creating upward pressure on the MCR for plans that stay.

Risk adjustment actuaries face a recalibration challenge. The V28 model's full implementation in 2026, combined with the DOJ investigation into UNH's coding practices, introduces uncertainty about the durability of risk scores across the industry. If enforcement actions result in reduced risk scores for UNH or broader industry coding practice changes, the revenue assumptions embedded in 2027 bids may prove optimistic.

The broader lesson from UnitedHealthcare's 2026 repricing is that Medicare Advantage has entered a phase where the growth-at-any-cost playbook of the 2018 to 2024 era no longer works. CMS rate deceleration, V28 risk score compression, Star Ratings volatility, and provider network exits have collectively narrowed the margin corridor to the point where carriers must choose between volume and profitability. UnitedHealthcare chose profitability. Whether that choice proves sustainable depends on actuarial variables, including risk pool stability, provider cost trends, and CMS rate adequacy, that will not be fully observable for another two to three bid cycles.

UnitedHealthcare Trades 1.3 Million MA Members for Margin Gains in the Largest Medicare Advantage Repricing in History